Biotech & Health
Williams··3 min read
Japan Marks Regenerative Medicine Milestone: World's First iPSC-Based Treatment Approved for Commercial Use
Japan has granted the first-ever regulatory approval for a medical product based on induced pluripotent stem cells (iPSCs), a breakthrough technology pioneered 20 years ago. This milestone marks the shift of regenerative medicine from the lab to commercial healthcare, offering new hope for spinal cord and nerve repair.
Williams··3 min read